These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway. Nuwormegbe SA; Sohn JH; Kim SW Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722 [TBL] [Abstract][Full Text] [Related]
5. TGF-β1, in association with the increased expression of connective tissue growth factor, induce the hypertrophy of the ligamentum flavum through the p38 MAPK pathway. Cao YL; Duan Y; Zhu LX; Zhan YN; Min SX; Jin AM Int J Mol Med; 2016 Aug; 38(2):391-8. PubMed ID: 27279555 [TBL] [Abstract][Full Text] [Related]
6. Electrophilic PPARγ ligands inhibit corneal fibroblast to myofibroblast differentiation in vitro: a potentially novel therapy for corneal scarring. Kuriyan AE; Lehmann GM; Kulkarni AA; Woeller CF; Feldon SE; Hindman HB; Sime PJ; Huxlin KR; Phipps RP Exp Eye Res; 2012 Jan; 94(1):136-45. PubMed ID: 22178289 [TBL] [Abstract][Full Text] [Related]
7. JNK and p38 Inhibitors Prevent Transforming Growth Factor-β1-Induced Myofibroblast Transdifferentiation in Human Graves' Orbital Fibroblasts. Hou TY; Wu SB; Kau HC; Tsai CC Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799469 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815 [TBL] [Abstract][Full Text] [Related]
9. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Burgess HA; Daugherty LE; Thatcher TH; Lakatos HF; Ray DM; Redonnet M; Phipps RP; Sime PJ Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1146-53. PubMed ID: 15734787 [TBL] [Abstract][Full Text] [Related]
10. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts]. Wang WM; Liu F; Chen N Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(11):740-4. PubMed ID: 16681946 [TBL] [Abstract][Full Text] [Related]
11. [Mechanism underlying the inhibitory effects of peroxisome proliferator-activated receptor γ agonists on transforming growth factor β1 in adult skin fibroblasts]. Yang CZ; Zhang HT; Wang GS; Zhou HQ; Ma C; Hu DH Zhonghua Shao Shang Za Zhi; 2010 Dec; 26(6):448-51. PubMed ID: 21223655 [TBL] [Abstract][Full Text] [Related]
12. Activation of JNK signaling mediates connective tissue growth factor expression and scar formation in corneal wound healing. Shi L; Chang Y; Yang Y; Zhang Y; Yu FS; Wu X PLoS One; 2012; 7(2):e32128. PubMed ID: 22363806 [TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor-gamma inhibits transforming growth factor-beta1 induction of connective tissue growth factor and extracellular matrix in hypertrophic scar fibroblasts in vitro. Zhang GY; Cheng T; Zheng MH; Yi CG; Pan H; Li ZJ; Chen XL; Yu Q; Jiang LF; Zhou FY; Li XY; Yang JQ; Chu TG; Gao WY Arch Dermatol Res; 2009 Aug; 301(7):515-22. PubMed ID: 19466435 [TBL] [Abstract][Full Text] [Related]
14. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells. Suk FM; Chen CH; Lin SY; Cheng CJ; Yen SJ; Hung LF; Liu DZ; Liang YC Toxicol Lett; 2009 May; 187(1):22-7. PubMed ID: 19429239 [TBL] [Abstract][Full Text] [Related]
15. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts. Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776 [TBL] [Abstract][Full Text] [Related]
16. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Utsugi M; Dobashi K; Ishizuka T; Masubuchi K; Shimizu Y; Nakazawa T; Mori M Am J Respir Cell Mol Biol; 2003 Jun; 28(6):754-61. PubMed ID: 12760970 [TBL] [Abstract][Full Text] [Related]
17. Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts. Koo JB; Nam MO; Jung Y; Yoo J; Kim DH; Kim G; Shin SJ; Lee KM; Hahm KB; Kim JW; Hong SP; Lee KJ; Yoo JH BMC Gastroenterol; 2017 Jun; 17(1):73. PubMed ID: 28592228 [TBL] [Abstract][Full Text] [Related]
18. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation. Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581 [TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells. Liu Y; Dai B; Xu C; Fu L; Hua Z; Mei C PLoS One; 2011; 6(12):e28915. PubMed ID: 22174924 [TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway. Lin CH; Yu MC; Tung WH; Chen TT; Yu CC; Weng CM; Tsai YJ; Bai KJ; Hong CY; Chien MH; Chen BC Biochim Biophys Acta; 2013 Dec; 1833(12):2823-2833. PubMed ID: 23906792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]